During pregnancy, placentas are extremely susceptible to various diseases and teratogens, so various medications with the ability to eradicate these problems are being tested. Current drug testing methods are considered to be unethical and unreliable, due to costs and the testing of medication on animals. Our research focuses on creating a microfluidic device that will allow us to move away from the drug testing of live subjects, and move towards a more ethical and effective method of testing.